Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44380 clinical trials with a EudraCT protocol, of which 7392 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,380)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

44,380 result(s) found. Displaying page 1,822 of 2,219.

EudraCT Number: 2021-005575-40	Sponsor Protocol Number: UZB-VHH2-4	Start Date*: 2023-02-15
Sponsor Name:UZ Brussel
Full Title: A phase II study to evaluate the imaging potential of 68GaNOTA-Anti-MMR VHH2 for in vivo imaging of MMR-expressing Macrophages by means of Positron Emission Tomography (PET) in patients with non-s...
Medical condition: Patients diagnosed with non-small cell lung cancer (NSCLC), planned for standard-of-care (SOC) surgery
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: BE (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2020-002728-35

Sponsor Protocol Number: HUN-AVI-01

Start Date*: 2020-09-17

Sponsor Name:Hungarian Ministry of Innovation and Technology - Representative: Hecrin Consortium

Full Title: An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients with Mild Pneumonia − An open-label randomized controlled study −

Medical condition: Patients with new type of coronavirus (SARS-CoV-2) infection proven by RT-PCR test with mild pneumonia.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.0	10021881 - Infections and infestations	10084268	COVID-19	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed)

Trial results: (No results available)

EudraCT Number: 2020-004928-42

Sponsor Protocol Number: REM-ENY-01

Start Date*: 2020-10-12

Sponsor Name:Hungarian Ministry of Innovation and Technology - Representative: Hecrin Consortium

Full Title: Open-label study to assess the safety of REMdesivir-HU as Eligible Novel therapY for moderate and severe Covid-19 patients

Medical condition: SARS-CoV-2 Infection

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.0	10021881 - Infections and infestations	10084268	COVID-19	PT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed)

Trial results: (No results available)

EudraCT Number: 2020-005096-12

Sponsor Protocol Number: OPRERA

Start Date*: 2021-05-31

Sponsor Name:Karolinska Universitetssjukhuset

Full Title: Utvärdering av två kortison behandlingsstrategier hos patienter med nydiagnostiserad, tidigare obehandlad reumatoid artrit: en randomiserad, öppen, non-inferiority klinisk studie

Medical condition: Rheumatoid arthritis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.1	10028395 - Musculoskeletal and connective tissue disorders	10039073	Rheumatoid arthritis	PT

Population Age:

Gender: Male, Female

Trial protocol: SE (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2022-003157-55

Sponsor Protocol Number: EF-39

Start Date*: 2023-03-30

Sponsor Name:Novocure GmbH

Full Title: PANOVA-4: Pilot, Single arm Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant with Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-Line Treatment for Metastatic Pancreatic Ductal ...

Medical condition: Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.0	100000004864	10033599	Pancreatic adenocarcinoma metastatic	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Prematurely Ended) CZ (Trial now transitioned) ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2023-000166-33

Sponsor Protocol Number: SLICK-001

Start Date*: 2023-04-12

Sponsor Name:Semmelweis University

Full Title: Implementation study of lipid management of high-risk cardiovascular patients- Semmelweis Lipid Center for high-risk patients

Medical condition: primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia in atherosclerotic cardiovascular disease

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.0	100000004861	10020604	Hypercholesterolemia	LLT
	20.0	100000004850	10054380	Familial hypercholesterolemia	LLT
	20.0	100000004850	10077966	Primary hypercholesterolemia	LLT
	21.0	100000004861	10058110	Dyslipidemia	LLT
	20.1	100000004861	10079969	Atherogenic dyslipidemia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2020-005738-13	Sponsor Protocol Number: TPLBIS20	Start Date*: 2021-02-16
Sponsor Name:Region Skåne
Full Title: Pivmecillinam with Amoxicillin/clavulanic acid for Step Down Oral Therapy in Febrile UTIs Caused by ESBL-producing Enterobacterales.
Medical condition: Urinary tract infection and/or bacteremia caused by extended spectrum beta-lactamases-producing Enterobacterales
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: SE (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2020-003715-94	Sponsor Protocol Number: IDEAL	Start Date*: 2020-12-17
Sponsor Name:Institute for Clinical and Experimental Medicine
Full Title: INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi
Medical condition: Type 2 diabetes mellitus
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: CZ (Completed) HU (Prematurely Ended)
Trial results: (No results available)

EudraCT Number: 2022-000492-39

Sponsor Protocol Number: XIN-XSTEM-201

Start Date*: 2022-07-05

Sponsor Name:Xintela AB

Full Title: A multi-centre, randomised, single-blind Phase I/IIa study to evaluate the safety, tolerability and efficacy of a single topical dose of allogeneic integrin α10β1-selected mesenchymal stem cells (X...

Medical condition: Difficult-to-heal venous leg ulcers

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	10040785 - Skin and subcutaneous tissue disorders	10047260	Venous ulceration	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2014-000810-72

Sponsor Protocol Number: PREDIXLumB

Start Date*: 2014-12-05

Sponsor Name:Karolinska University Hospital

Full Title: PREDIX Luminal B - Neoadjuvant response-guided treatment of estrogen receptor positive tumors with high proliferation or slow proliferation with metastatic nodes or young patients. Part of a set of...

Medical condition: Primary breast cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10006200	Breast cancer stage II	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10006201	Breast cancer stage III	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10006191	Breast cancer male NOS	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10006188	Breast cancer female NOS	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2023-000945-18

Sponsor Protocol Number: 219449

Start Date*: 2024-10-28

Sponsor Name:GlaxoSmithKline Biologicals

Full Title: A Phase 2 single-blind, randomized, controlled, single center study to assess the immunogenicity and safety of a 2-dose schedule with GVGH altSonflex1-2-3 vaccine in African infants (H06_02TP)

Medical condition: Prophylaxis for Shigellosis induced by Shigella sonnei, Shigella flexneri 1b, Shigella flexneri 2a and Shigella flexneri 3a.

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10021881 - Infections and infestations	10040550	Shigella infections	HLT
	27.1	10021881 - Infections and infestations	10054178	Shigella infection	PT
	20.0	10021881 - Infections and infestations	10040542	Shigella	LLT
	20.0	10021881 - Infections and infestations	10040547	Shigella flexneri	LLT
	20.0	10021881 - Infections and infestations	10040551	Shigella sonnei	LLT
	20.1	10021881 - Infections and infestations	10004016	Bacterial diarrhoea	PT
	20.0	10017947 - Gastrointestinal disorders	10012735	Diarrhoea	PT

Population Age: Infants and toddlers, Under 18

Gender: Male, Female

Trial protocol: Outside EU/EEA

Trial results: (No results available)

EudraCT Number: 2020-001617-21	Sponsor Protocol Number: 72864	Start Date*: 2020-08-27
Sponsor Name:Aarhus University Hospital
Full Title: The Effect of Trimetazidine on Mitochondrial Function, Myocardial Performance, and Invasive Hemodynamics in Patients Diagnosed with Wild-Type Transthyretin Cardiac Amyloidosis.
Medical condition: Wild-Type Transthyretin Cardiac Amyloidosis
Disease:
Population Age: Elderly		Gender: Male, Female
Trial protocol: DK (Completed)
Trial results: View results

EudraCT Number: 2017-003832-35

Sponsor Protocol Number: HIPEC/FLOT9

Start Date*: 2020-07-27

Sponsor Name:Institute of Clinical Cancer Research (IKF) Krankenhaus Nordwest

Full Title: Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction Type II/III adenocarcinoma – The phase III “PREVENT” tri...

Medical condition: locally advanced resectable diffuse type adenocarcinoma of the oesophagogastric junction or the stomach

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10062878	Gastrooesophageal cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2021-004981-37	Sponsor Protocol Number: BMXBAR01	Start Date*: 2022-01-19
Sponsor Name:Helse Bergen HF
Full Title: Benzodiazepine maintenance treatment for patients with benzodiazepine dependence undergoing opioid agonist therapy (BMX-BAR)
Medical condition: Benzodiazepine dependence
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: NO (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2020-000273-24

Sponsor Protocol Number: RG_19-282

Start Date*: 2020-10-06

Sponsor Name:University of Birmingham

Full Title: Venetoclax or Intensive Chemotherapy for Treatment Of Favourable Risk Acute Myeloid Leukaemia: A Molecularly Guided Phase 2 Study

Medical condition: Acute Myeloid Leukaemia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10000880	Acute myeloid leukaemia	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA) DK (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2022-003009-31

Sponsor Protocol Number: HH007

Start Date*: 2022-12-23

Sponsor Name:Zealand University Hospital, dept. of Haematology

Full Title: Atorvastatin for patients with Philadelphia-negative chronic myeloproliferative neoplasms - Essential thrombocythemia, polycythemia vera and prefibrotic myelofibrosis

Medical condition: Essential thrombocythemia, Polycythemia vera, prefibrotic myelofibrosis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10077465	Myeloproliferative neoplasm	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: DK (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2021-006497-23	Sponsor Protocol Number: 870128	Start Date*: 2022-07-05
Sponsor Name:Helsinki University Hospital
Full Title: Corticosteroid in treatment of acute laryngitis among vocal professionals
Medical condition: Laryngitis
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: FI (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2020-005123-36	Sponsor Protocol Number: PARASTOP	Start Date*: 2021-07-05
Sponsor Name:Oslo University Hospital
Full Title: A randomized, double-blind, parallel-group non-inferiority phase III withdrawal trial of paracetamol versus placebo in conjunction with opioids for moderate to severe cancer-related pain
Medical condition: Adult patients with metastatic cancer disease, cancer-related pain treated with regular strong opioids, receiving paracetamol (1 gram three or four times a day) and with average pain intensity past...
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: NO (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2014-005376-29	Sponsor Protocol Number: 2014-100757	Start Date*: 2015-06-29
Sponsor Name:Academic Medical Center, Gastroenterology
Full Title: An open-label observational phase 4 study to evaluate efficacy , safety and mucosal healing of early versus late use of vedolizumab in Crohn's disease: the LOVE-CD study (LOw countries VEdolizumab ...
Medical condition: Active Crohn's disease
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: NL (Completed) BE (Completed) HU (Completed)
Trial results: (No results available)

EudraCT Number: 2020-000105-92

Sponsor Protocol Number: CLMI070C12203

Start Date*: 2021-10-15

Sponsor Name:Novartis Pharma AG

Full Title: A Randomized, Double-Blind, Placebo-Controlled Dose Range Finding Study with Open-Label Extension to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LMI070/branaplam whe...

Medical condition: Huntington's disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10010331 - Congenital, familial and genetic disorders	10070668	Huntington's disease	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) HU (Completed) ES (Temporarily Halted) FR (Completed) IT (Prematurely Ended) BE (Completed) LT (Prematurely Ended)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Tue Feb 10 15:15:40 CET 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA